Annual revenue:
$2.85B+$434.69M(+17.97%)Summary
- As of today (April 19, 2025), BMRN annual revenue is $2.85 billion, with the most recent change of +$434.69 million (+17.97%) on December 31, 2024.
- During the last 3 years, BMRN annual revenue has risen by +$1.01 billion (+54.58%).
- BMRN annual revenue is now at all-time high.
Performance
BMRN Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$747.31M+$1.57M(+0.21%)Summary
- As of today (April 19, 2025), BMRN quarterly revenue is $747.31 million, with the most recent change of +$1.57 million (+0.21%) on December 31, 2024.
- Over the past year, BMRN quarterly revenue has stayed the same.
- BMRN quarterly revenue is now at all-time high.
Performance
BMRN Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$2.85B+$101.11M(+3.67%)Summary
- As of today (April 19, 2025), BMRN TTM revenue is $2.85 billion, with the most recent change of +$101.11 million (+3.67%) on December 31, 2024.
- Over the past year, BMRN TTM revenue has stayed the same.
- BMRN TTM revenue is now at all-time high.
Performance
BMRN TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
BMRN Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +18.0% | 0.0% | 0.0% |
| 3 y3 years | +54.6% | 0.0% | 0.0% |
| 5 y5 years | +67.5% | 0.0% | 0.0% |
BMRN Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +54.6% | at high | +47.9% | at high | +51.8% |
| 5 y | 5-year | at high | +67.5% | at high | +82.8% | at high | +58.1% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
BioMarin Pharmaceutical Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $2.85B(+18.0%) | $747.31M(+0.2%) | $2.85B(+3.7%) |
| Sep 2024 | - | $745.74M(+4.7%) | $2.75B(+6.4%) |
| Jun 2024 | - | $712.03M(+9.7%) | $2.59B(+4.7%) |
| Mar 2024 | - | $648.83M(+0.4%) | $2.47B(+2.2%) |
| Dec 2023 | $2.42B(+15.4%) | $646.21M(+11.2%) | $2.42B(+4.7%) |
| Sep 2023 | - | $581.33M(-2.3%) | $2.31B(+3.4%) |
| Jun 2023 | - | $595.27M(-0.2%) | $2.23B(+2.8%) |
| Mar 2023 | - | $596.41M(+11.0%) | $2.17B(+3.7%) |
| Dec 2022 | $2.10B(+13.5%) | $537.54M(+6.4%) | $2.10B(+4.4%) |
| Sep 2022 | - | $505.34M(-5.3%) | $2.01B(+5.1%) |
| Jun 2022 | - | $533.80M(+2.8%) | $1.91B(+1.7%) |
| Mar 2022 | - | $519.36M(+15.5%) | $1.88B(+1.8%) |
| Dec 2021 | $1.85B(-0.8%) | $449.81M(+10.0%) | $1.85B(-0.1%) |
| Sep 2021 | - | $408.74M(-18.5%) | $1.85B(-3.6%) |
| Jun 2021 | - | $501.69M(+3.2%) | $1.92B(+3.9%) |
| Mar 2021 | - | $486.03M(+7.5%) | $1.84B(-0.9%) |
| Dec 2020 | $1.86B(+9.2%) | $452.12M(-5.2%) | $1.86B(-0.1%) |
| Sep 2020 | - | $476.78M(+11.0%) | $1.86B(+0.8%) |
| Jun 2020 | - | $429.49M(-14.5%) | $1.85B(+2.3%) |
| Mar 2020 | - | $502.04M(+10.5%) | $1.81B(+5.9%) |
| Dec 2019 | $1.70B(+14.3%) | $454.44M(-1.4%) | $1.70B(+6.3%) |
| Sep 2019 | - | $461.10M(+18.9%) | $1.60B(+4.5%) |
| Jun 2019 | - | $387.76M(-3.2%) | $1.53B(+1.0%) |
| Mar 2019 | - | $400.75M(+13.4%) | $1.52B(+1.8%) |
| Dec 2018 | $1.49B(+13.5%) | $353.26M(-9.8%) | $1.49B(-0.3%) |
| Sep 2018 | - | $391.71M(+5.1%) | $1.50B(+4.0%) |
| Jun 2018 | - | $372.85M(-0.2%) | $1.44B(+4.0%) |
| Mar 2018 | - | $373.45M(+4.2%) | $1.38B(+5.3%) |
| Dec 2017 | $1.31B(+17.6%) | $358.31M(+7.2%) | $1.31B(+4.6%) |
| Sep 2017 | - | $334.15M(+5.3%) | $1.26B(+4.5%) |
| Jun 2017 | - | $317.45M(+4.5%) | $1.20B(+1.5%) |
| Mar 2017 | - | $303.75M(+1.2%) | $1.18B(+6.0%) |
| Dec 2016 | $1.12B(+25.5%) | $300.09M(+7.2%) | $1.12B(+6.9%) |
| Sep 2016 | - | $279.90M(-6.7%) | $1.04B(+7.3%) |
| Jun 2016 | - | $300.13M(+26.8%) | $973.71M(+5.4%) |
| Mar 2016 | - | $236.74M(+3.9%) | $923.71M(+3.8%) |
| Dec 2015 | $889.89M(+18.8%) | $227.94M(+9.1%) | $889.89M(-0.2%) |
| Sep 2015 | - | $208.90M(-16.5%) | $892.03M(+3.8%) |
| Jun 2015 | - | $250.13M(+23.3%) | $859.67M(+7.3%) |
| Mar 2015 | - | $202.92M(-11.8%) | $801.32M(+6.8%) |
| Dec 2014 | $749.28M(+36.6%) | $230.07M(+30.3%) | $749.96M(+12.5%) |
| Sep 2014 | - | $176.55M(-7.9%) | $666.76M(+6.3%) |
| Jun 2014 | - | $191.79M(+26.5%) | $627.09M(+9.6%) |
| Mar 2014 | - | $151.55M(+3.2%) | $572.11M(+4.3%) |
| Dec 2013 | $548.49M(+9.5%) | $146.87M(+7.3%) | $548.49M(+2.8%) |
| Sep 2013 | - | $136.87M(+0.0%) | $533.55M(+1.7%) |
| Jun 2013 | - | $136.81M(+6.9%) | $524.79M(+2.5%) |
| Mar 2013 | - | $127.93M(-3.0%) | $512.00M(+2.3%) |
| Dec 2012 | $500.72M | $131.94M(+3.0%) | $500.72M(+5.1%) |
| Sep 2012 | - | $128.12M(+3.3%) | $476.63M(+3.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2012 | - | $124.02M(+6.3%) | $461.94M(+3.0%) |
| Mar 2012 | - | $116.65M(+8.2%) | $448.55M(+1.6%) |
| Dec 2011 | $441.36M(+17.3%) | $107.85M(-4.9%) | $441.36M(+1.4%) |
| Sep 2011 | - | $113.42M(+2.5%) | $435.13M(+3.7%) |
| Jun 2011 | - | $110.63M(+1.1%) | $419.45M(+4.7%) |
| Mar 2011 | - | $109.46M(+7.7%) | $400.77M(+6.5%) |
| Dec 2010 | $376.27M(+15.9%) | $101.61M(+4.0%) | $376.27M(+4.0%) |
| Sep 2010 | - | $97.75M(+6.3%) | $361.74M(+4.9%) |
| Jun 2010 | - | $91.95M(+8.2%) | $344.79M(+2.7%) |
| Mar 2010 | - | $84.95M(-2.4%) | $335.63M(+3.4%) |
| Dec 2009 | $324.66M(+9.5%) | $87.08M(+7.8%) | $324.66M(-3.6%) |
| Sep 2009 | - | $80.81M(-2.4%) | $336.85M(+2.5%) |
| Jun 2009 | - | $82.79M(+11.9%) | $328.69M(+6.0%) |
| Mar 2009 | - | $73.98M(-25.5%) | $310.08M(+4.6%) |
| Dec 2008 | $296.49M(+143.9%) | $99.28M(+36.7%) | $296.49M(+22.5%) |
| Sep 2008 | - | $72.65M(+13.2%) | $242.07M(+24.5%) |
| Jun 2008 | - | $64.17M(+6.3%) | $194.43M(+22.2%) |
| Mar 2008 | - | $60.40M(+34.7%) | $159.14M(+30.9%) |
| Dec 2007 | $121.58M(+44.4%) | $44.85M(+79.4%) | $121.58M(+23.1%) |
| Sep 2007 | - | $25.01M(-13.4%) | $98.75M(+0.1%) |
| Jun 2007 | - | $28.88M(+26.5%) | $98.67M(+5.8%) |
| Mar 2007 | - | $22.84M(+3.7%) | $93.23M(+10.7%) |
| Dec 2006 | $84.21M(+228.1%) | $22.02M(-11.7%) | $84.21M(+17.5%) |
| Sep 2006 | - | $24.93M(+6.3%) | $71.66M(+31.9%) |
| Jun 2006 | - | $23.45M(+69.8%) | $54.32M(+57.5%) |
| Mar 2006 | - | $13.81M(+45.8%) | $34.49M(+34.4%) |
| Dec 2005 | $25.67M(+37.7%) | $9.47M(+25.0%) | $25.67M(-14.7%) |
| Sep 2005 | - | $7.58M(+109.0%) | $30.09M(+32.6%) |
| Jun 2005 | - | $3.63M(-27.3%) | $22.69M(-4.0%) |
| Mar 2005 | - | $4.99M(-64.1%) | $23.63M(+26.8%) |
| Dec 2004 | $18.64M(+54.1%) | $13.90M(+7577.9%) | $18.64M(+292.9%) |
| Sep 2004 | - | $181.00K(-96.0%) | $4.74M(+4.0%) |
| Jun 2004 | - | $4.56M(-62.3%) | $4.56M(-70.9%) |
| Dec 2003 | $12.10M(+24.6%) | - | - |
| Jun 2003 | - | $12.10M(+239.0%) | $15.67M(+45.3%) |
| Sep 2002 | - | $3.57M(+4.3%) | $10.78M(-1.6%) |
| Jun 2002 | - | $3.42M(-9.7%) | $10.96M(+3.9%) |
| Mar 2002 | - | $3.79M(+1.3%) | $10.55M(+5.8%) |
| Sep 2001 | - | $3.74M(+24.3%) | $9.97M(+10.4%) |
| Jun 2001 | - | $3.01M(+12.0%) | $9.04M(-0.8%) |
| Mar 2001 | - | $2.69M(+411.4%) | $9.11M(-6.3%) |
| Dec 2000 | $9.71M(+83.3%) | $526.00K(-81.3%) | $9.71M(-0.8%) |
| Sep 2000 | - | $2.81M(-9.0%) | $9.79M(+9.0%) |
| Jun 2000 | - | $3.08M(-6.5%) | $8.98M(+19.8%) |
| Mar 2000 | - | $3.30M(+449.7%) | $7.50M(+41.4%) |
| Dec 1999 | $5.30M(+341.7%) | $600.00K(-70.0%) | $5.30M(+12.8%) |
| Sep 1999 | - | $2.00M(+25.0%) | $4.70M(+74.0%) |
| Jun 1999 | - | $1.60M(+44.9%) | $2.70M(+144.9%) |
| Mar 1999 | - | $1.10M | $1.10M |
| Dec 1998 | $1.20M | - | - |
FAQ
- What is BioMarin Pharmaceutical annual revenue?
- What is the all time high annual revenue for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical annual revenue year-on-year change?
- What is BioMarin Pharmaceutical quarterly revenue?
- What is the all time high quarterly revenue for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical quarterly revenue year-on-year change?
- What is BioMarin Pharmaceutical TTM revenue?
- What is the all time high TTM revenue for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical TTM revenue year-on-year change?
What is BioMarin Pharmaceutical annual revenue?
The current annual revenue of BMRN is $2.85B
What is the all time high annual revenue for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high annual revenue is $2.85B
What is BioMarin Pharmaceutical annual revenue year-on-year change?
Over the past year, BMRN annual revenue has changed by +$434.69M (+17.97%)
What is BioMarin Pharmaceutical quarterly revenue?
The current quarterly revenue of BMRN is $747.31M
What is the all time high quarterly revenue for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high quarterly revenue is $747.31M
What is BioMarin Pharmaceutical quarterly revenue year-on-year change?
Over the past year, BMRN quarterly revenue has changed by $0.00 (0.00%)
What is BioMarin Pharmaceutical TTM revenue?
The current TTM revenue of BMRN is $2.85B
What is the all time high TTM revenue for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high TTM revenue is $2.85B
What is BioMarin Pharmaceutical TTM revenue year-on-year change?
Over the past year, BMRN TTM revenue has changed by $0.00 (0.00%)